cholic acid has been researched along with Cerebral Cholesterinosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Björkhem, I; Lütjohann, D; Stellaard, F | 1 |
| Bove, KE; Heubi, JE; Setchell, KDR | 1 |
| Besson, G; Castelnovo, G; Chaussenot, A; Curot, J; Douillard, C; Duval, F; Giral, P; Lamari, F; Lecerf, JM; Mandia, D; Nadjar, Y; Pierdet, H; Roland, D | 1 |
| Blyth, J; Chakrapani, A; McKiernan, P; Pierre, G; Preece, MA; Setchell, K | 1 |
| Båvner, A; Björkhem, I; Hansson, M; Leitersdorf, E; Meiner, V; Olin, M; Shafaati, M; Shpitzen, S | 1 |
| Bezerra, JM; Cerqueira, AC; Nardi, AE | 1 |
| Clayton, PT; Mann, A; Mieli-Vergani, G; Sistermans, E; Verrips, A; Wevers, R | 1 |
1 review(s) available for cholic acid and Cerebral Cholesterinosis
| Article | Year |
|---|---|
Inborn Errors of Bile Acid Metabolism.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Acyl-CoA Oxidase; Adrenal Hyperplasia, Congenital; Amino-Acid N-Acetyltransferase; Bile Acids and Salts; Cholestasis; Cholic Acid; Genetic Testing; Humans; Liver Diseases; Metabolism, Inborn Errors; Racemases and Epimerases; Steroid Hydroxylases; Xanthomatosis, Cerebrotendinous | 2018 |
6 other study(ies) available for cholic acid and Cerebral Cholesterinosis
| Article | Year |
|---|---|
Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosis.
Topics: Adult; Biomarkers; Cholic Acid; Humans; Hydroxycholesterols; Xanthomatosis, Cerebrotendinous | 2020 |
Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults.
Topics: Adult; Cholestanol; Cholesterol; Cholic Acid; Female; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Xanthomatosis, Cerebrotendinous | 2019 |
Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy.
Topics: Age Factors; Aging; Child; Child Behavior; Child Development; Child, Preschool; Cholestasis; Cholic Acid; Developmental Disabilities; Early Diagnosis; Female; Humans; Infant; Intelligence Tests; Male; Motor Activity; Neurologic Examination; Predictive Value of Tests; Treatment Outcome; Xanthomatosis, Cerebrotendinous | 2008 |
On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase.
Topics: Animals; Brain; Brain Chemistry; Cholestanetriol 26-Monooxygenase; Cholestanol; Cholestenones; Cholestyramine Resin; Cholic Acid; Female; Humans; Liver; Male; Mice; Mice, Knockout; Molecular Structure; Tendons; Xanthomatosis, Cerebrotendinous | 2010 |
Cerebrotendinous xanthomatosis: a treatable hereditary neuro-metabolic disease.
Topics: Adult; Cholic Acid; Humans; Male; Nervous System Diseases; Treatment Outcome; Xanthomatosis, Cerebrotendinous | 2010 |
Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis.
Topics: Adolescent; Adult; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestanols; Cholestasis; Cholic Acid; DNA; Exons; Gas Chromatography-Mass Spectrometry; Hepatitis; Humans; Male; Mutation; Steroid Hydroxylases; Xanthomatosis, Cerebrotendinous | 2002 |